Asthma

Investigators found that intralymphatic immunotherapy of was not superior to placebo or other forms of allergen-specific immunotherapy, but felt continued research was warranted.

Investigators found that despite a lack of infrastructure on pediatric quality improvement, higher-performing hospitals can sustain cost-effective strategies for pediatric asthma care.

Though no research on the effects of positive emotion intervention on children with asthma exist, investigators note that the methods have shown positive results in other health contexts.

A new follow-up study highlights the efficacy and safety of the daily oral immunotherapy in. younger patient populations.

A new study suggests the Asthma Predictive Index can be used as a simple, noninvasive tool for determining asthma in preschoolers.

Research showed that the second dose of the COVID-19 vaccine was well tolerated by patients who experienced allergic reactions from their first dose.

The biologic can now be used as an add-on maintenance treatment for patients who have struggled with former treatment and surgeries.

Researchers in North Carolina recorded improvements in pediatric healthcare utilization partly attributed to a lack of exposure to allergens and other exacerbations.

The new kinoid vaccine has shown positive results in mice with human proteins, and the France-based team remain optimistic of human trials in the future.

Roughly 60% of participants in the SINUS-24 and SINUS-52 trials reported improvements in the severity of loss-of-taste.

Researchers in the UK recommend early detection and treatment of food allergy and sensitization to avoid complications in adulthood.

Dr. Jorge Maspero speaks of the complications of severe chronic rhinosinusitis with nasal polyps and how dupilumab could improve the daily struggles patients face.

Despite a global decrease in asthma deaths, researchers say the disease is particularly threatening to patients with atopic dermatitis.

Dr. Jorge Maspero speaks of the recent successes of the two newest trials, and what they could mean for the future of chronic rhinosinusitis management.

The new PDUFA date for the biologic has been scheduled for early 2022.

Researchers found that different pets elicit different allergy responses in child participants.

Investigators suggest symptoms in asthmatic patients are more severe, although it does not result in higher mortality rates.

The monoclonal antibody has proved effective in combatting the spread of fibrocytes in asthmatic individuals.

A new Polish study calls for greater focus on asthma and the link to delirium in older patients, who may face greater mortality risk.

There are no guidelines on sickle cell patient referral to pulmonologists, associated outcomes, and best therapeutic interventions.

An expert discussion on climate change and air pollution effects on communities, including increased COVID-19 rates.

The newest findings show the TSLP inhibitor is beneficial over 52 weeks in patients aged 12-80 years old.

Meredith McCormack, MD discusses consequences of high air pollution levels in the United States found in the 2021 American Lung Association State of the Air Report.

Climate change health experts Poune Saberi, MD, and Alan S. Greenglass, MD, join Lungcast for a timely discussion on environmental health issues.

The 2021 annual report finds that Los Angeles remains the most polluted US city, while negative impacts of climate change and COVID-19 are both linked to increased pollution rates.